文献速递心外重症与机械循环支持

循环死亡后捐献显著缩短心脏移植等待时间且不改变移植后结局:基于美国器官共享联合网络的分析

Donation after circulatory death significantly reduces waitlist times while not changing post-heart transplant outcomes: A United Network for Organ Sharing Analysis.
PubMed 文献 · J Heart Lung Transplant · 2023-10-18

该研究基于美国器官共享联合网络数据库,纳入2019年1月至2022年6月10402例成人心脏移植受者,其中循环死亡后捐献(DCD)425例(4%)、脑死亡后捐献(DBD)9977例(96%)。DCD组移植后早期生存与DBD组相似,调整后等待时间更短,尤其在状态4至6的候选者中缩短约5倍。

要点

  • DCD心脏移植占同期成人心脏移植的4%,受者多为预计等待时间较长者(如 durable LVAD、状态>4)。
  • 匹配与未匹配队列中DCD与DBD移植后早期生存相似(p=0.22)。
  • DCD组调整后等待时间21天 vs DBD组31天,状态4至6候选者中DCD 22天 vs DBD 115天。

核心结论

  • DCD心脏移植受者移植后早期生存与DBD受者相似,且调整后等待时间更短。
  • 鉴于早期成功,作者认为应努力利用DCD扩大供者池,尤其针对等待名单上传统弱势受者。

研究设计与样本

  • 基于美国器官共享联合网络数据库的回顾性分析,纳入2019年1月至2022年6月10402例成人(年龄>18岁)心脏移植受者,其中DCD 425例(4%)、DBD 9977例(96%)。

主要发现

  • DCD与DBD受者年龄相似(均为57岁,p=0.791)。
  • DCD受者更可能为白人(67% vs 60%,p=0.002)、使用左心室辅助装置(LVAD;40% vs 32%,p<0.001)、列为状态4至6(60% vs 24%,p<0.001),但较少需要正性肌力药(22% vs 40%,p<0.001)和术前体外膜肺氧合(0.9% vs 6%,p<0.001)。
  • DCD供者更年轻(29 vs 32岁,p<0.001),肾功能不全(15% vs 39%,p<0.001)、糖尿病(1.9% vs 3.8%,p=0.050)和高血压(9.9% vs 16%,p=0.001)比例更低。
  • 匹配与未匹配队列中早期生存相似(p=0.22)。
  • DCD组调整后等待时间较DBD组更短(21 vs 31天,p<0.001);状态4至6候选者中DCD组22天 vs DBD组115天(p<0.001),该状态占DCD队列的60%。

临床怎么用

  • 原文未据此给出具体临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Recently, several centers in the United States have begun performing donation after circulatory death (DCD) heart transplants (HTs) in adults. We sought to characterize the recent use of DCD HT, waitlist time, and outcomes compared to donation after brain death (DBD). METHODS: Using the United Network for Organ Sharing database, 10,402 adult (aged >18 years) HT recipients from January 2019 to June 2022 were identified: 425 (4%) were DCD and 9,977 (96%) were DBD recipients. Posttransplant outcomes in matched and unmatched cohorts and waitlist times were compared between groups. RESULTS: DCD and DBD recipients had similar age (57 years for both, p = 0.791). DCD recipients were more likely White (67% vs 60%, p = 0.002), on left ventricular assist device (LVAD; 40% vs 32%, p < 0.001), and listed as status 4 to 6 (60% vs 24%, p < 0.001); however, less likely to require inotropes (22% vs 40%, p < 0.001) and preoperative extracorporeal membrane oxygenation (0.9% vs 6%, p < 0.001). DCD donors were younger (29 vs 32 years, p < 0.001) and had less renal dysfunction (15% vs 39%, p < 0.001), diabetes (1.9% vs 3.8%, p = 0.050), or hypertension (9.9% vs 16%, p = 0.001). In matched and unmatched cohorts, early survival was similar (p = 0.22). Adjusted waitlist time was shorter in DCD group (21 vs 31 days, p < 0.001) compared to DBD cohort and 5-fold shorter (DCD: 22 days vs DBD: 115 days, p < 0.001) for candidates in status 4 to 6, which was 60% of DCD cohort. CONCLUSIONS: The community is using DCD mostly for those recipients who are expected to have extended waitlist times (e.g., durable LVADs, status >4). DCD recipients had similar posttransplant early survival and shorter adjusted waitlist time compared to DBD group. Given this early success, efforts should be made to expand the donor pool using DCD, especially for traditionally disadvantaged recipients on the waitlist.

来源:J Heart Lung Transplant,查看原文。版权归原作者所有。

引用

  1. Ahmed HF, Kulshrestha K, Kennedy JT, et al. Donation after circulatory death significantly reduces waitlist times while not changing post-heart transplant outcomes: A United Network for Organ Sharing Analysis. J Heart Lung Transplant. 2023. PMID: 37863451. doi:10.1016/j.healun.2023.10.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。